Aravive to delist from Nasdaq Stock Market

Aravive announced that the company intends to voluntarily terminate the listing of its common stock on the Nasdaq Global Select Market and, based upon ownership of its shares by fewer than 300 holders of record, deregister its common stock under the Securities Exchange Act of 1934, as amended and suspend its public reporting obligations. As previously disclosed, at the company’s 2023 annual stockholder’s meeting, the stockholders of the company approved effecting a transfer and assignment of all or substantially all of the company’s assets to an assignee for the benefit of creditors and the dissolution and liquidation of the company, each subject to the company’s board making a determination that such actions were in the best interests of the company. On January 12, 2024, the board approved the transfer of all or substantially all of the company’s assets through an assignment for the benefit of creditors and the voluntary dissolution and liquidation of the company.